Loading
Latest filing published 24 Mar 2023 for 派林生物, €134k.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
黄灵谋 (board member) discloses dealings in 派林生物 to SSE / SZSE (CSRC). The record holds 4 filings, for trades running from 14 September 2021 to 24 March 2023.
In open-market terms, that means 1 purchase worth €360k on one side and 3 sales worth €436k on the other. The net balance comes to €76k on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2023: no purchases and 3 sales on the market.
On 24 March 2023 came the latest disclosure, an open-market sale for €134k in 派林生物. The clock since the last published purchase (14 September 2021) now reads 1,868 days. Most trades are made public on the day they happen. Until a filing is published, the market cannot know about the trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations